Candida auris and COVID-19 : A health threatening combination
Copyright: © 2021, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center..
Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic's potential effect on antifungal drug resistance.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Current medical mycology - 8(2022), 3 vom: 10. Sept., Seite 44-50 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khojasteh, Shaghayegh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antifungal resistance |
|---|
| Anmerkungen: |
Date Revised 15.04.2023 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18502/cmm.8.3.11211 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355559102 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355559102 | ||
| 003 | DE-627 | ||
| 005 | 20231226064614.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18502/cmm.8.3.11211 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1185.xml |
| 035 | |a (DE-627)NLM355559102 | ||
| 035 | |a (NLM)37051551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khojasteh, Shaghayegh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Candida auris and COVID-19 |b A health threatening combination |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2021, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center. | ||
| 520 | |a Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic's potential effect on antifungal drug resistance | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antifungal resistance | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Co-infection | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Candida auris | |
| 700 | 1 | |a Jafarzdeh, Jalal |e verfasserin |4 aut | |
| 700 | 1 | |a Hosseini, Seyed Abdollah |e verfasserin |4 aut | |
| 700 | 1 | |a Haghani, Iman |e verfasserin |4 aut | |
| 700 | 1 | |a Turki, Habibollah |e verfasserin |4 aut | |
| 700 | 1 | |a Aghaei Gharehbolagh, Sanaz |e verfasserin |4 aut | |
| 700 | 1 | |a Abastabar, Mahdi |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudi, Shahram |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current medical mycology |d 2015 |g 8(2022), 3 vom: 10. Sept., Seite 44-50 |w (DE-627)NLM273575279 |x 2423-3439 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2022 |g number:3 |g day:10 |g month:09 |g pages:44-50 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18502/cmm.8.3.11211 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2022 |e 3 |b 10 |c 09 |h 44-50 | ||